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Abstract 
Genome-wide studies have identified allele A (adenine) of single nucleotide 
polymorphism (SNP) rs1006737 of the calcium-channel CACNA1C gene as a risk 
factor for both schizophrenia (SZ) and bipolar disorder (BD) as well as allele A for 
rs1344706 in the zinc-finger ZNF804A gene. These illnesses have also been 
associated with white matter abnormalities, reflected by reductions in fractional 
anisotropy (FA), measured using diffusion tensor imaging (DTI). We assessed the 
impact of the CACNA1C psychosis risk variant on FA in SZ, BD and health. 230 
individuals (with existing ZNF804A rs1344706 genotype data) were genotyped for 
CACNA1C rs1006737 and underwent DTI. FA data was analysed with tract-based 
spatial statistics and threshold-free cluster enhancement significance correction 
(p<0.05) to detect effects of CACNA1C genotype on FA, and its potential interaction 
with ZNF804A genotype and with diagnosis, on FA. There was no significant main 
effect of the CACNA1C genotype on FA, nor diagnosis by genotype(s) interactions.  
Nevertheless, when inspecting SZ in particular, risk allele carriers had significantly 
lower FA than the protective genotype individuals, in portions of the left middle 
occipital and parahippocampal gyri, right cerebelleum, left optic radiation and left 
inferior and superior temporal gyri. Our data suggests a minor involvement of 
CACNA1C rs1006737 in psychosis via conferring susceptibility to white matter 
microstructural abnormalities in SZ. Put in perspective, ZNF804A rs1344706, not 
only had a significant main effect, but its SZ-specific effects were two orders of 
magnitude more widespread than that of CACNA1C rs1006737.  
 
 5 
Introduction 
Schizophrenia (SZ) and bipolar disorder (BD) are major psychiatric illnesses that 
have profound effects on a person’s mood, cognition and behavior. Psychotic and 
negative symptomatology, and cognitive impairments are common to both, albeit 
these are more severe for SZ (Green et al., 2010). Lifetime prevalence of SZ and BD 
is about 4% (Bhugra, 2005) and 0.5% respectively (Merikangas et al., 2007). Both 
illnesses are highly heritable: up to 80% (SZ) and 93% (BD) (Gurung & Prata, 2015) 
but their common and  specific aetiological and pathophysiological causes are poorly 
understood. 
 
Genome-wide association studies (GWAS) have identified two genetic variants 
conferring, so far the most reproducible, risk for both SZ and BD: allele A of the 
single nucleotide polymorphism (SNP) labelled rs1006737 of the CACNA1C gene 
(Ferreira et al., 2008, Green et al., 2010, Guan et al., 2014, He et al., 2014, Jiang et 
al., 2015, Nyegaard et al., 2010, Sklar et al., 2008, Zheng et al., 2014) and allele A of 
the rs1344706 SNP of the ZNF804A gene (Donohoe et al., 2010, Sun et al., 2015, 
Zhang et al., 2015, Zhu et al., 2014). The latter variant has been associated with white 
matter (WM) microstructural abnormalities as we report elsewhere (Mallas et al., 
2016). 
 
The CACNA1C gene, located on the short arm of chromosome 12p13.3 encodes an 
alpha-1 subunit of a voltage dependent L-type calcium-channel (LTCC) referred to as 
CaV1.2. LTCCs regulate the influx of calcium ions into the cell upon polarisation of 
the membrane, and, being widely expressed in the central nervous system (CNS), are 
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involved in various processes including regulation of signalling pathways, 
neurotransmitter release and neuronal excitability. CaV1.2 is thought to be important 
in synaptic plasticity and neuronal gene expression (Uemura et al., 2015). 
 
SZ and BD have also been robustly associated with WM abnormalities. Fractional 
anisotropy (FA) measured using diffusion tensor imaging (DTI) is a putative proxy of 
WM microstructural integrity (Jones et al., 2013) and decreases in FA can thus be 
regarded as being indicative of reduced WM integrity. Additionally, FA is highly 
heritable: 75-90% of the variance in FA across almost all WM regions could be 
explained by genetic factors (Chiang et al., 2009). Several studies have reported FA 
reductions in psychotic probands, with similar abnormalities to an attenuated degree, 
observed in healthy first-degree relatives (Chaddock et al., 2009, Skudlarski et al., 
2013, Sprooten et al., 2012), and FA has been found to decrease with increasing 
genetic liability to psychosis (Emsell et al., 2013, Phillips et al., 2011). Reduced FA 
is a replicated finding in SZ, and to a lesser extent, in BD, in a diverse range of brain 
regions (Ellison-Wright & Bullmore, 2009, Vederine et al., 2011). Furthermore, 
reduced FA can be detected in both the prodromal and early stages of illness (Carletti 
et al., 2012, Cheung et al., 2008, Karlsgodt et al., 2008, Szeszko et al., 2005), 
suggesting that microstructural abnormalities in WM are involved in the underlying 
neuropathophysiology of the disease.  
 
Imaging genetics evidence of the impact of CACNA1C rs1006737 on WM 
microstructure is sparse. The risk allele has recently been associated with reduced FA 
in the right hippocampal formation in Caucasian healthy subjects in a study 
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researching this location only (Dietsche et al., 2014). In another study whole-brain but 
non WM-tract-based, SZ Chinese patients carrying the risk allele have also shown 
lower mean FA in the left frontal lobe, left parietal lobe and left temporal lobe, 
compared to G homozygotes while healthy G homozygotes show higher mean FA 
compared to A-allele carriers in the right cingulate gyrus and left temporal lobe 
(Woon et al., 2014). However, none of these studies have provided whole-brain WM 
tract-based evidence of an impact on FA, thus providing limited resolution of this 
SNP’s effects. Moreover, no study has researched the impact of this SNP in a clinical 
population. 
 
In this study we aimed to assess for the first time the effect of the genome-wide risk 
variant allele A for rs1006737 of CACNA1C on tract-based regional FA throughout 
the whole brain in a large (n=230) and predominantly Caucasian (83%) sample of 
non-clinical controls and SZ and BD patients. Unprecedentedly, we also enquire if 
CACNA1C rs1006737 is modulated by diagnosis and by the other most GWAS-
implicated SNP: the rs1344706 of the ZNF804A gene (for our review of GWAS-
implicated genes on brain phenotypes, see (Gurung & Prata, 2015); the impact of the 
ZNF804A gene on psychiatric disorders is discussed in more detail in our previously 
reported work (Mallas et al., 2016). We predicted that the risk allele (A) of 
CACNA1C rs1006737 would be associated with reduced FA across all subjects, 
irrespective of diagnosis, but might have a greater effect in the patient (SZ and BD) 
groups. We also anticipated that the effect of this risk allele might be augmented by 
the presence of the risk allele A of ZNF804A rs1344706. 
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Material and Methods 
Participants 
The total sample of 230 subjects consisted of patients with SZ (n=63), patients with 
BD (type 1 or type 2; 77% of which with psychosis; n=43) and non-clinical controls 
(n=124), who had participated in seven previous research imaging studies at the 
Institute of Psychiatry, Psychology & Neuroscience, King’s College London (Allin et 
al., 2011, Chaddock, 2009, Chaddock et al., 2009, Kyriakopoulos et al., 2009, 
Picchioni et al., 2006, Shergill et al., 2007). Individuals were collated from those sub-
samples, with any relatives excluded, as detailed elsewhere (Mallas et al., 2016).  
 
Each participant was assigned to three groups: a diagnosis group (SZ, BD or control), 
and after genotyping (see below), a genotype group for CACNA1C in terms of risk 
allele load (CAC+: A homozygotes and heterozygotes; and CAC-: allele G (guanine) 
homozygotes), and for ZNF804A (ZNF+: A homozygotes; and ZNF-: heterozygotes 
and C (cytosine) homozygotes). ZNF grouping is discussed in Mallas et al. (2016). 
Cell sizes (averaging 19.2 subjects) are shown in Supplementary Material 1. The 
grouping of genotype groups had the purpose of maximising counterbalance for the 
rs1006737 CACNA1C SNP, as commonly practiced in the literature (Backes et al., 
2014, Dietsche et al., 2014, Nieratschker et al., 2015, Ou et al., 2015, Woon et al., 
2014) given the much lower frequency counts of allele A, compared to C, in the 
Caucasian population. The SNPs reported in this manuscript are the only SNPs 
analysed in this imaging data set. 
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The study was approved by the National Health Service (NHS) South East London 
Research Ethics Committee, UK (Project “Genetics and Psychosis (GAP)” reference 
number 047/04). All subjects provided written informed consent at the time of 
participation. Patients were recruited from the South London and Maudsley (SLaM) 
NHS Trust. Diagnosis, according to the criteria of the Diagnostic and Statistical 
Manual of Mental Disorders (DSM) 4
th
 Edition (American.Psychiatric.Association & 
Dsm-Iv., 1994) was ascertained by an experienced psychiatrist using a structured 
diagnostic interview with instruments detailed elsewhere (Prata et al., 2009). All SZ 
and BD patients were in a stable clinical state and all SZ and some BD were treated 
with antipsychotic medication (from which Chlorpromazine-equivalence was 
calculated, see Table 1).  
 
Exclusion criteria applied to all participants were a history of significant head injury 
and current (last 12 months) substance dependency according to DSM-IV diagnostic 
criteria. Non-clinical controls were excluded if they had any personal or family 
history of a psychotic spectrum disorder. In order to follow the gold standard of 
experimental design that a control group must be matched to the experimental group 
on all variables except the one isolated for study, and avoid a biased ‘super-normal’ 
control group (Kendler, 2003), participants with a previous, but not present, diagnosis 
of any other Axis I disorder (or family history) were not excluded given these are 
frequently present in SZ and BD (as such, two controls had once in the past been 
diagnosed with mild depression). None were psychiatrically unwell or on any 
psychiatric medication at the time of participation.  
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Genotyping 
DNA was extracted from blood samples or buccal swabs following a standard 
protocol (Freeman et al., 1997, Freeman et al., 2003) and a TaqMan SNP Genotyping 
Assay (Applied.Biosystems, 2010) for CACNA1C SNP rs1006737 (A/G) and 
ZNF804A rs1344706 (A/C) was performed blind to any phenotype data, at the Social 
Genetic and Developmental Psychiatry Centre (SGDP) lab, King’s College London.  
 
Genotype counts did not differ significantly from those quoted in the National Center 
for Biotechnology Information (NCBI) database for CACNA1C rs1006737 (92 GG, 
96 AG, 42 AA, χ2=0.41, df=2, p=0.815) nor deviated significantly (p<0.05) from 
Hardy-Weinberg Equilibrium (HWE) in Caucasians (χ2= 1.33, p=0.25, df=1); HWE 
could not be calculated for the other ethnicities due to insufficient counts for a χ2 test, 
in each. HWE was calculated using Michael H. Court’s online calculator (Court, 
2005-2008). There were no further polymorphisms genotyped in this sample.  
 
Image Acquisition 
Magnetic Resonance Imaging (MRI) data were acquired using a 1.5T GE Signal LX 
system (General Electric, Milwaukee, WI, USA) in the Mapother House MR unit at 
the Maudsley Hospital, South London and Maudsley (SLaM) NHS Foundation Trust, 
London, UK. The scanner had actively shielded magnetic field gradients (maximum 
amplitude 40mT/m1), and a quadrature birdcage head coil was used for both 
radiofrequency (RF) transmission and signal reception. Each volume of DTI data was 
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acquired using a multi-slice peripherally-gated echo planar imaging (EPI) sequence, 
optimised for precise measurement of the diffusion tensor in parenchyma, from 60 
contiguous near-axial slice locations for whole brain coverage, with isotropic 
(2.5x2.5x2.5 mm) voxel size. At each slice location, 7 images were acquired with no 
diffusion gradients applied (b=0), together with 64 diffusion-weighted images in 
which gradient directions were uniformly distributed in space. Acquisition parameters 
were as follows: echo time (TE) =107ms, effective repetition time =15 R-R intervals, 
duration of the diffusion encoding gradients = 17.3ms, with a maximum diffusion 
weighting =1300s/mm
2
. Further details of the methodology are given elsewhere 
(Jones et al., 2002). 
 
 
DTI Data Processing 
The raw DTI data were corrected for head movement and eddy-current induced 
distortions, and then brain-extracted using the Brain Extraction Tool (BET) (Smith, 
2002) in order to exclude non-brain voxels. After visual inspection of images, the 
BET threshold was adjusted to 0.2 to ensure a balance between complete scalp 
removal and inappropriate erosion of brain tissue that had not been achieved using the 
default parameter setting of 0.5. FA images were then created (with a mask defined 
by a binarised version of this brain-extracted image) by fitting a tensor model to the 
raw diffusion data using the Functional MRI of the Brain lab (FMRIB)’s Diffusion 
Toolbox (FDT) within FMRIB software library (FSL) as described elsewhere 
(Behrens et al., 2003). 
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Voxel-wise statistical analysis of the FA data was carried out using tract-based spatial 
statistics (TBSS) (Smith et al., 2006), also part of FSL (Smith et al., 2004). Briefly: 
all subjects’ FA data were aligned to FMRIB58_FA 1x1x1mm standard space (an 
average of the FA images of 58 healthy adults) using the nonlinear registration tool 
FNIRT (Andersson et al., 2007a, Andersson et al., 2007b), which uses a b-spline 
representation of the registration warp field (Rueckert et al., 1999). The entire aligned 
dataset was then affine-transformed into a 1x1x1mm MNI152 space, resulting in a 
standard space version of each subject’s FA image, from which the mean FA image 
was created and thinned to create a mean FA skeleton. Each subject's aligned FA data 
were then projected onto this skeleton and the resulting data fed into voxel-wise 
cross-subject statistics. 
 
Group-level Statistical Analyses 
Demographic differences between diagnostic or genotype groups, were tested using 
independent t-tests, Chi-Square and Analysis of Variance (ANOVA) in Statistical 
Package for Social Sciences (SPSS) v21 (Corp., 2012) .  
 
The FSL Randomise tool (Anderson & Robinson, 2001) was used to perform 
permutation-based non-parametric inferences on the skeletonised FA data at a 
threshold of 0.2 (TBSS default) with 10,000 permutations. The significance level was 
set at p<0.05 after multiple comparisons correction using threshold-free cluster 
enhancement (TFCE) (Smith & Nichols, 2009), an approach that allows the 
significance of a target voxel to take into account not only the amplitude of the signal 
(in this case FA) but also the contribution of both the spatial extent and the magnitude 
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of supporting voxels. To assess the main effect of CACNA1C genotype, of ZNF804A 
genotype, and of diagnostic group as well as their interactions on FA, an ANOVA 
design matrix was built with CACNA1C genotype (CAC+ vs. CAC-), ZNF804A 
genotype (ZNF+ vs. ZNF-) and diagnosis (SZ, BD and controls) as the three 
independent variables, and age as a covariate in effects where age differed 
significantly across groups. The main effect of diagnosis and of ZNF has been 
reported in detail elsewhere (Mallas et al., 2016). We will also report simple effects 
for completeness. The ‘Cluster’ tool in FSL was used to define clusters within the 
statistical images. The mean FA within the largest cluster of each effect was 
graphically plotted for visual display of effects.  
 
WM labelling based on the JHU ICBM-DTI-81 WM Atlas (Mori et al., 2008) 
provided by the Atlasquery tool FSL, was used to determine the anatomical location 
of significant FA clusters; only with greater than 1% probability of being part of the 
WM in question were included in the cluster table. Where cluster results were 
retrieved as ‘Unclassified’, labelling was carried out manually by FC using the MRI 
Atlas of Human WM (Mori et al., 2005). Results were overlaid on MNI152 (1mm) 
standard template and displayed in radiological convention.  
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Results  
Demographics 
Participant demographic data are shown in Table 1. BD patients (mean age = 41.1, 
SD =12.3) were significantly older than SZ patients (mean age =33.8, SD =10.7) and 
controls (mean age = 35.8, SD =13.40), while there was no significant difference in 
age between the control and the SZ group. There were significantly (χ2 =17.2, 
p<0.001) more males (50M:13F) in SZ than BD (18M:25F) or control (67M:57F) 
groups. There was a significant difference (χ2 =11.17, df =4, p =0.03) in genotype 
distribution between diagnostic groups. SZ patients (mean CPZ score =696.9, SD 
=613.0) had a significantly higher (t(104) =3.3, p<0.001) CPZ-equivalent score than 
BD (mean CPZ score = 341.6, SD =434.6). There were no other significant 
differences between diagnostic groups in IQ, years of education, ethnicity or 
handedness. There was a significant difference in the distribution of ethnicities 
between CAC+ and CAC- (χ2 = 14.37, df =6, p =0.03) but no other significant 
differences between the genotype groups in IQ, age, chlorpromazine (CPZ) 
equivalents in medication, years of education or handedness. ZNF804A genotype-wise 
demographics differed only for ethnicity (χ2 =20.86, df =6, p<0.001) given the a priori 
different allele frequencies between African and Caucasian populations. Full details 
are reported elsewhere (Mallas et al., 2016) and displayed in Supporting Material 2.  
 
Effect of CACNA1C Genotype on FA 
Whole-brain, voxel-based TBSS retrieved no significant main effect of CACNA1C 
rs1006737 genotype on FA in the total sample. However, as a secondary result, there 
was a significant (p<0.05, TFCE-corrected) simple effect of genotype within the SZ 
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group alone (Figure 1a), in which FA was significantly lower in the SZ CAC+ than in 
the SZ CAC- group. This effect encompasses WM portions of the left middle 
occipital and parahippocampal gyri, right cerebelleum, left optic radiation and left 
inferior and superior temporal gyri (Figure 1c; Table 2). No effect in the opposite 
direction was significant in any location, either as a main effect or within SZ, BD or 
controls separately. 
 
Interactions involving CACNA1C Genotype, ZNF804A Genotype and/or 
diagnosis on FA 
Before correcting for age, there was a significant (p<0.05, TFCE-corrected) 3-way 
interaction between CACNA1C rs1006737 genotype, ZNF804A rs1344706 genotype 
and diagnosis affecting the body of the corpus callosum, the right superior corona 
radiata and the left anterior corona radiata, the largest cluster spanning 125 voxels. 
This reflected that the presence of the risk genotype of ZNF804A (ZNF+; vs. ZNF-) 
increased the magnitude of the effect of the CACNA1C risk genotype (CAC+; vs. 
CAC-) on FA, in BD patients more than in controls. However, this effect was no 
longer significant when age (which was significantly higher in BD than controls or SZ 
groups) was added into the model as a covariate. No other locations showed 
alternative interaction patterns of this 3-way ANOVA. 
 
Effect of Diagnosis on FA 
Both SZ and BD had significantly reduced FA compared to the control group. There 
was no significant difference in FA between patient groups, nor were there regions 
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where FA was significantly decreased in the control group compared to patient 
groups. We have previously reported this in detail (Mallas et al., 2016).  
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Discussion 
We assessed the effect across the human brain of the CACNA1C rs1006737 genotype on FA, 
unprecedentedly in a Caucasian clinical sample as well as in health, and whether this genotype 
effect was different between diagnostic groups and whether it interacted with the ZNF804A 
rs1344706 genotype. Although using a relatively large sample for imaging analysis, we detected 
no significant (p<0.05, TFCE-corrected) main effects or interaction effects from an ANOVA. 
 
As a result of a complementary analysis to our main hypotheses of main and interaction effects, 
we detected statistically significant, albeit small, effect (p<0.05, TFCE-corrected), in the 
predicted direction, in our SZ sample alone. This is the first evidence of an association between 
CACNA1C rs1006737 risk allele A and reduced FA in a predominantly Caucasian clinical 
sample. This result may suggest the involvement of the GWA-implicated linkage 
disequilibrium region tagged by allele A at CACNA1C rs1006737 locus in influencing 
susceptibility to psychosis by demonstrating its effect in reducing FA in the SZ population. This 
putatively reflects changes in WM microstructure and reduction of WM integrity in SZ. 
Comparatively, both the effect in SZ and the overall main effect of genotype that we found for 
another top GWA-implicated ZNF804A rs1344706 was much larger and more spatially 
expansive (Mallas et al., 2016): the main effect of ZNF804A genotype spanned more than 
44,054 voxels in the largest cluster and its effect in SZ only, spanned 51,260 voxels. Thus, one 
should put these polymorphisms’ effect in perspective: both the effects of ZNF804A genotype 
spanned an location of about 2 orders of magnitude larger than the one under the CACNA1C 
genotype effects we report herein. 
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Given that we found an effect of CACNA1C in SZ but not in controls, but a CACNA1C 
genotype by diagnosis interaction was not significant, it is possible that power was not 
sufficient to detect the latter. We encourage further studies to use a larger sample study to detect 
whether SZ does indeed increase susceptibility to a CACNA1C rs1006737 effects. Our finding 
that FA in SZ patients carrying the risk allele was significantly lower than in SZ non-risk allele 
carriers is consistent with those reported by Woon et al. (2014) in a Chinese SZ population of 
similar size (96 SZ and 64 controls). However, in our study we found an effect in the left 
middle occipital gyrus, left parahippocampal gyrus, left optic radiation and left temporal gyrus 
WM, while Woon et al. (2014) reported the left frontal lobe, left parietal lobe and left temporal 
lobe WM. We found significantly reduced FA in the right cerebellar WM, whilst Woon et al. 
(2014) found it on the left. Unfortunately, precise comparisons with their study are limited by 
the different approaches: while we report comparatively more precise (TBSS) tract-based or 
gyri, they report very wide lobes. 
 
In our non-clinical volunteers, the high risk A allele carriers did not differ significantly in any 
brain region’s FA compared to the low risk G homozygotes, for CACNA1C rs1006737. This is 
inconsistent with recent positive findings reported by Dietsche et al. (2014) of decreased FA in 
the right hippocampal formation in non-clinical A allele carriers. A possible explanation is that 
Dietsche et al. (2014) focused on one region of interest (ROI) in contrast to our whole-brain 
analysis, thus allowing a more relaxed multiple comparisons correction in their selected 
location. 
 
We also report the first test of a CACNA1C and ZNF804A interaction. We predicted their 
respective GWAs-implicated risk SNPs would interact in an additive manner, the risk 
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increasing when both risk allele groups were present (e.g. CAC+ and ZNF+) – in consistency 
with the hypothesis that both these polymorphisms increase the risk for psychosis, and that 
psychosis is associated with a (widespread) decrease in FA. Prior to covarying for age, we 
found, albeit only in BD compared to controls (and surprisingly not in SZ vs. controls), that the 
concomitant presence of both risk alleles was represented more in subjects with relatively 
decreased FA in the body of the corpus callosum, the right superior corona radiata and the left 
anterior corona radiata. However, when we added age as a covariate to the model this effect did 
not survive significance, suggesting that the difference in BD patients’ age (vs controls or SZ) 
across genotype groups had driven this interaction effect. Further research therefore needs to 
explore this effect in a larger, age matched sample. 
 
Structural volumetric imaging studies have also implicated the CACNA1C rs1006737 risk-allele 
in increased regional (Frazier et al., 2014) and total (Kempton et al., 2009, Wang et al., 2011) 
gray matter volumes in non-clinical controls, inclusive in a dose-dependent manner (Kempton 
et al., 2009). Others have found the same trend in the amygdala and hypothalamus (Perrier et 
al., 2011) irrespective of diagnosis, and, in SZ patients specifically, the amygdala (Wolf et al., 
2014). However, a larger sample of almost 600 healthy subjects failed to replicate this 
association (Franke et al., 2010), as did another study in amygdala and hippocampal volumes, 
in BD patients and healthy controls (Soeiro-De-Souza et al., 2012). Regarding WM, the risk 
allele has also been associated with increased total and fronto-limbic volumes (Frazier et al., 
2014). 
 
Functional MRI studies have also implicated the CACNA1C rs1006737 risk allele (A) in 
candidate behavioural intermediate phenotypes for BD and SZ, it being associated with 
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increased activation (and thus putatively ‘inefficient’ when performance differences are 
controlled for) in the left inferior frontal gyrus and left precuneus during a verbal fluency task 
(Krug et al., 2010), in which performance is often impaired in SZ and BD (Krabbendam et al., 
2005). The same allele has also been associated with increased activation in the left amygdala in 
BD patients in a face-matching task (Tesli et al., 2013), increased hippocampal and prefrontal 
activation during emotional processing and executive cognition tasks respectively (Bigos et al., 
2010), and enhanced right amygdala response both during a monetary reward task (Wessa et al., 
2010) and a face recognition task (Jogia et al., 2011). In contrast, response reductions in 
bilateral hippocampal (Erk et al., 2010), medial frontal gyrus (Thimm et al., 2011) and right 
dorso-lateral prefrontal cortex (dlPFC) (Paulus et al., 2013) have also been associated with this 
allele during episodic memory, executive control of attention and working memory tasks 
respectively. While the findings of reduced activation are harder to reconcile, those of 
(putatively inefficiently) increased activation during cognitive executive tasks provide 
converging support to our finding that the same risk allele is influencing WM microstructural 
abnormalities. Nevertheless, further research combining fMRI-based and DTI-based 
connectivity would be paramount to adequately test to what extent localized functional 
cognitive deficits are caused by FA deficits affecting the same regions.  
 
Regarding the influence of the illnesses on the CACNA1C rs1006737 genotype effect, Jogia et 
al. (2011) observed a significant genotype x diagnosis interaction in the right ventro-lateral 
prefrontal cortex, where risk-allele carriers in the BD group, but not unaffected relatives’ nor 
unrelated controls, showed reduced activation. Furthermore, in a partial superset of the current 
sample, including 20 BD patients, 20 unaffected first-degree relatives and 20 unrelated healthy 
controls, Radua et al. (2013) found a similar genotype x diagnosis interaction, this time on 
effective brain connectivity. The risk allele A was associated with decreased outflow of 
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information from the medial frontal gyrus during perception of fearful faces, significantly more 
so in BD than relatives or controls. This disruption in connectivity is a plausible consequence of 
WM microstructural abnormalities we found herein and thus supports the idea that this 
genotypic variation exerts its functional effect, to a greater extreme in an illness context, via a 
disruption in WM microstructure.  
 
Supporting the plausibility that genetic factors, such as CACNA1C rs1006737 A allele, could 
increase risk of psychosis through predisposing individuals to abnormalities in WM 
microstructure, are heritability studies of WM. These have suggested that genetic factors 
explain a large proportion of the variance in WM inter-individual differences (originally 
estimated at around 88% (Baaré et al., 2001)) with a meta-analysis of over 50 studies further 
supporting the genetic basis of total and regional WM volumes (Blokland et al., 2012). 
Mechanism-wise, it is possible that CACNA1C rs1006737 exerts its effect through altering 
levels of CACNA1C mRNA expression. As rs1006737 is located in a non-coding region of the 
gene, it is not thought that this SNP directly interferes with CaV1.2 properties. The risk allele 
(A) was associated with increased mRNA expression of CACNA1C in induced human neurons, 
and increased density of Cav1.2-mediated currents (Yoshimizu et al., 2014), albeit it was also 
found to be associated with decreased expression in the human cerebellum (Gershon et al., 
2014). As the latter authors state, this may suggest that either an increase or decrease of calcium 
influx in excitable cells might be associated with BD, as both could lead to changes in 
monoamine neurotransmitter synthesis and release (Gershon et al., 2014) which has been 
associated with psychiatric disorders (Booij et al., 2003). Nevertheless, a more comprehensive 
characterization of this polymorphism’s impact on mRNA levels across different brain regions 
is still warranted. 
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In conclusion, and in combination with our previous work (Mallas et al., 2016), we provide 
evidence that the genomic regions tagged by the two most significantly genome-wide associated 
psychosis risk variants for SZ and BD (in the genes for CACNA1C and ZNF804A) may increase 
susceptibility to abnormal WM microstructure and, as such, to psychosis. Effects of the 
respective causative ZNF804A polymorphism were demonstrated to be two orders of magnitude 
more widespread (and present as a main effect as well as a SZ-specific effect) compared to 
those of the CACNA1C one (where only a SZ-specific effect was found). 
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Tables and Figures 
Figure 1. Effect of CACNA1C rs1006737 genotype on fractional anisotropy. 
 
Figure Legend: Figure 1. a. FA was significantly reduced in SZ CAC+ group (i.e. risk A allele carriers for 
rs1006737) compared to the SZ CAC- group (i.e. protective G allele homozygotes (p<0.05, TFCE corrected) in 
locations labelled in red in this figure’s section; b. The difference in FA between CAC+ and CAC- was not 
statistically significant anywhere in the BD or control groups alone, nor irrespective of diagnosis. b. Figure 
depicting locations where in SZ, the CAC+ group showed significantly reduced FA compared to the CAC- group. 
Significant clusters displayed in red overlaid on MNI template in radiological view.  
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Table 1. Participant Demographics.  
Participant Demographics (n=230) 
  
                              Diagnosis CACNA1C rs1006737 Genotype 
SZ  
(n=63) 
BD  
(n=43) 
Control  
(n=124) 
Test Statistic, df,  
p-value 
CAC+ 
(AA/AG;n=138) 
CAC- 
(GG; n=92) 
Test Statistic, df, 
p-value 
Age (SD) 33.78 (10.70) 
41.07 
(12.33) 
35.79 
(13.40) 
F=4.5, df=2, p=0.01† 
 
34.86 (12.56) 38.28 (12.56) 
 t (228) = 2.018, 
p=0.05* 
IQ: z-scores (SD)§ -0.75 (2.89) 
-0.87 
(0.97) 
-0.68 (3.51) F=0.70, df=2, p=0.50 
-0.60 (2.78) -0.56 (3.27) t (197) = 0.08, 
p=0.94 
Antipsychotics dose (in CPZ 
equivalent; SD) 
696.94 
(613.02) 
341.60 
(434.56) 
n/a 
F=10.75, 
df=1, p=0.00† 
 
291.15 (530.70) 200.18 
(376.18) 
t (227.11) = -1.52, 
p=0.13 
Years of Education (SD) 13.74 (2.61) 
14.81 
(3.10) 
14.90 
(2.79) 
F=2.51, df=2, p=0.08 
14.57 (2.98) 14.57 (2.68) t (162) = 0.01, p 
=0.99 
Sex (M/F) 50/13 18/25 67/57 
χ2 =17.24, df=2, p=0.00† 
 
83/55 52/40 χ2 = 0.30, df=1, 
p=0.59 
  
  
  
  
  
Ethnicity 
White 46 40 104 
χ2 =13.90, df=12, p=0.31 
112 78 
 
 
 
 
 
χ2=14.37, df=6, 
p=0.03* 
Black 
Caribbean 
6 1 4 10 1 
Black African 5 2 6 9 4 
Central Asian 3 0 4 5 2 
Mixed African 
and White 
2 0 1 2 1 
Eastern Asian 0 0 3 0 3 
  
Other 1 0 2 0 3 
  Right 62 38 112 
χ2 =5.79, df=4, p=0.22 
128 84 
χ2=0.35, df=2, 
p=0.84 
Handedness Left 0 3 5 4 4 
  
Mixed 1 2 7 6 4 
Genotype (%) 
AA 10 (16%) 15 (35%) 17 (14%)     
AG 30 (48%) 15 (35%) 51 (41%) χ2 =11.17, df=4, p=0.03*    
GG 23 (37%) 13 (30%) 56 (45%)     
Footnote: n/a = not applicable; †statistically significant at 95% level. CAC+: High risk (AA/AG genotypes); CAC-: Low risk (GG genotypes); BD: Bipolar Disorder; SZ: Schizophrenia; SD: Standard deviation; df: 
degrees of freedom. 
§Scores of full scale IQ from the Wechsler Abbreviated Scale of Intelligence (WASI) (Wechsler, 1999), the Wechsler Adult Intelligence Scale – Revised (WAIS-R) (Wechsler, 1981) or the National Adult Reading Test 
(NART) (Nelson & Willison, 1991), were standardised to Z-scores to permit between-group demographic comparison. The type of test used was balanced between diagnostic or genotype groups. 
 
 
 
 25 
 
Table 2: White matter labels corresponding to clusters showing significant effects on fractional anisotropy (p<0.05 after TFCE 
correction).  
 
 
 
Cluster Size 
(Voxels) 
Cluster Maximum 
Z-statistic 
Cluster MAX Co-ordinates 
White Matter Labels a 
 X Y Z 
 
SZ-specific effect CACNA1C (CAC+<CAC-) 
 
133 0.982 44 -69 8 WM of the L middle occipital gyrus 
60 0.975 -31 -31 -15 WM of the L parahippocampal gyrus 
47 0.967 8 -58 -46 R cerebellar WM 
36 0.983 -20 -92 10 L optic radiation 
35 0.967 -39 -14 -24 Subcortical WM of the L inferior temporal gyrus 
24 0.958 -58 -40 -3 Subcortical WM of the L superior temporal gyrus 
 
 
 
Footnote: CAC+: High risk (AA/AG genotypes); CAC-: Low risk (GG genotypes); SZ: Schizophrenia. 
a Only tracts with clusters at >1% probability are included. White matter labels are provided in accordance with JHU ICBM-DTI-81 White Matter Atlas (Mori et al., 2008) using 
AtlasQuery in FSL unless marked with “*”, in which case they were labelled by FC based on MRI Atlas of Human White Matter, 1st Edition by Mori et al., 2005 (Mori et al., 2005) 
due to retrieval from AtlasQuery returning as ‘Unclassified’.  
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